Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
about
Premedication with midazolam nasal spray: an alternative to oral midazolam in children.Pharmacokinetics and pharmacodynamics of nasally delivered midazolamIntranasal delivery of antiepileptic medications for treatment of seizures.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Alternative delivery systems for agents to treat acute agitation: progress to date.Review article: Paediatric status epilepticus in the pre-hospital setting: An update.Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects.Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study.Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disability.Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical Trial.Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.Liposome-encapsulated midazolam for oral administration.
P2860
Q33601124-7AE62878-DB5E-47AD-8037-1217A4280689Q33906315-0F297BB3-4F6A-4A08-9F26-389D55426B34Q37427001-6737BD70-25DA-4E1B-836A-D38F1D5B53F0Q37695055-2EC051DB-6D50-40E0-8D9F-BE3DD1D50225Q38154852-5F69145E-9360-44BF-B636-D1DDC757BEEFQ38669567-B267EFE7-7666-4459-8DF1-C6DAA1B22D61Q40670280-4D50F58A-FF97-4A33-B87A-4AA5BC785034Q42660247-7487E11D-D059-4F63-9910-44AE85D3E238Q46546877-1A9A49A7-9B72-41BA-8A45-D6A31993681EQ47245083-172C1E69-3534-4064-9E8B-DE0D43BA8CEAQ47367812-F8C95051-8BFD-4AD9-A9C4-7CFE266AB1EEQ47373267-827D312D-B0BF-4243-86F8-4977E088A33CQ47657036-E82D842E-C664-4125-94AE-2192CF60EA42Q48337514-1BF3CAE9-6B92-4B57-AE39-43267FD5FB80
P2860
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@en
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@nl
type
label
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@en
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@nl
prefLabel
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@en
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@nl
P2093
P1476
Pharmacokinetics and pharmacod ...... ulation in healthy volunteers.
@en
P2093
Anita C Rudy
Daniel P Wermeling
Kenneth A Record
Sanford M Archer
Thomas Clinch
Thomas H Kelly
P304
344-9, table of contents
P356
10.1213/01.ANE.0000226150.90317.16
P407
P577
2006-08-01T00:00:00Z